MYMD PHARMACEUTICALS INC (MYMD)
US62856X2018 - Common Stock
| TTM (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -5.39M | -15.20M | -29.89M | -12.15M | -3.89M | |||
| Depreciation Amortization | N/A | N/A | 0.00 | 30.00K | 70.00K | |||
| Change In Working Capital | 40.00K | 2.23M | -5.18M | 820.00K | -180.00K | |||
| Interest Paid | 0.00 | 0.00 | 270.00K | 0.00 | 0.00 | |||
| Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | -7.95M | 700.00K | 15.55M | -620.00K | 920.00K | |||
| OPERATING CASH FLOW | -13.30M | -12.27M | -19.52M | -11.92M | -3.07M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Investing Activity | -1.41M | 6.91M | 19.85M | -8.76M | -3.94M | |||
| INVESTING CASH FLOW | -1.41M | 6.91M | 19.85M | -8.76M | -3.94M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | -1.12M | N/A | N/A | |||
| Stock Issued/Repurchased | 14.69M | 5.55M | 1.19M | 38.67M | 6.97M | |||
| Dividend Paid | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 14.69M | 5.55M | 70.00K | 38.67M | 6.97M | |||
| CHANGE IN CASH | -20.00K | 190.00K | 400.00K | 17.99M | -40.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -13.30M | -12.27M | -19.52M | -11.92M | -3.07M | |||
| Capital Expenditure | N/A | N/A | N/A | N/A | 0.00 | |||
| FREE CASH FLOW | -13.30M | -12.27M | -19.52M | -11.92M | -3.07M | |||
All data in USD